KRT17 and familial pancreatic carcinoma: Although K17 impacts numerous hallmarks of cancer [5] and has been established as a defining biomarker of the basal molecular subtypes of pancreatic cancer [35, 46, 47] emerging clinical and research data support its mechanistic role in the regulation of the immune response [5, 6].